(Hypertension. 1997;30:942-947.)
© 1997 American Heart Association, Inc.
Articles |
From the Institut National de la Santé et de la Recherche Médicale (INSERM) U141 and U348 (J.M.), IFR Circulation Lariboisière, Université Paris VII, Paris, France.
Correspondence to D. Henrion, PhD, INSERM U141, Hôpital Lariboisière, 41 Bd de la Chapelle, 75475 Paris, Cedex 10, France. E-mail daniel.henrion{at}inserm.lrb.ap-hop-paris.fr
Abstract In human and experimental hypertension, flow (shear
stress)induced dilation in large arteries is attenuated and
resistant to nitric oxide blockade. We tested the hypothesis
that a defect in nitric oxideand/or
prostaglandin-dependent flow-induced dilation might occur
in mesenteric resistance arteries from spontaneously hypertensive rats
(SHR). We measured resistance mesenteric artery diameter in situ by
intravital microscopy and simultaneously measured
mesenteric arterial pressure in a collateral artery. The
flow-diameter-pressure relationship was established in normotensive
Wistar-Kyoto rats (WKY) and in SHR under control conditions and after
endothelium removal, inhibition of nitric oxide
synthesis with N
-nitro-L-arginine
methyl ester (10 µmol/L), or inhibition of
prostaglandin synthesis with indomethacin
(10 µmol/L). Production of prostaglandins
was determined in the perfusate. Endothelium
removal decreased artery diameter by 14±1.6% in WKY and 5±0.5%
(P<.01 versus WKY) in SHR at a flow rate of 400 µL/min.
In WKY, N
-nitro-L-arginine methyl
ester and indomethacin decreased resistance artery
diameter by 12±3% (P<.001) and 5±2%
(P<.01), respectively, at a flow rate of 400 µL/min;
neither substance had any significant effect in SHR. In both strains,
flow induced the production of 6-keto-prostaglandin
F1
, the metabolite of prostacyclin;
prostaglandin F2
; and
thromboxane B2, the stable metabolite of
thromboxane A2. Production of
6-keto-prostaglandin F1
and
prostaglandin F2
was
significantly lower in SHR than WKY, and TxB2
production was significantly higher in SHR than WKY. The
present findings suggest that in SHR mesenteric resistance
arteries, dilation in response to increases in flow was
resistant to nitric oxide and prostaglandin
synthesis blockade. A modification of the ratio of vasodilator to
vasoconstrictor prostaglandins might be at least partly
responsible for the decreased dilator response to flow in SHR.
Key Words: blood vessels nitric oxide rats, inbred SHR prostaglandins
This article has been cited by other articles:
![]() |
F. R. Perez, F. Venegas, M. Gonzalez, S. Andres, C. Vallejos, G. Riquelme, J. Sierralta, and L. Michea Endothelial Epithelial Sodium Channel Inhibition Activates Endothelial Nitric Oxide Synthase via Phosphoinositide 3-Kinase/Akt in Small-Diameter Mesenteric Arteries Hypertension, June 1, 2009; 53(6): 1000 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Su, P. A. Lucchesi, R. A. Gonzalez-Villalobos, D. I. Palen, B. M. Rezk, Y. Suzuki, H. A. Boulares, and K. Matrougui Role of Advanced Glycation End Products With Oxidative Stress in Resistance Artery Dysfunction in Type 2 Diabetic Mice Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1432 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Palen, S. Belmadani, P. A. Lucchesi, and K. Matrougui Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells Cardiovasc Res, November 1, 2005; 68(2): 268 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Duke, R. G. Evans, and R. E Widdop AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2289 - H2297. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lucchesi, A. Sabri, S. Belmadani, and K. Matrougui Involvement of Metalloproteinases 2/9 in Epidermal Growth Factor Receptor Transactivation in Pressure-Induced Myogenic Tone in Mouse Mesenteric Resistance Arteries Circulation, December 7, 2004; 110(23): 3587 - 3593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bolla, D. You, L. Loufrani, B. I. Levy, S. Levy-Toledano, A. Habib, and D. Henrion Cyclooxygenase Involvement in Thromboxane-Dependent Contraction in Rat Mesenteric Resistance Arteries Hypertension, June 1, 2004; 43(6): 1264 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Loufrani, C. Dubroca, D. You, Z. Li, B. Levy, D. Paulin, and D. Henrion Absence of Dystrophin in Mice Reduces NO-Dependent Vascular Function and Vascular Density: Total Recovery After a Treatment with the Aminoglycoside Gentamicin Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 671 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srivastava, R. L. Terjung, and H. T. Yang Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1190 - H1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Loufrani, B. I. Levy, and D. Henrion Defect in Microvascular Adaptation to Chronic Changes in Blood Flow in Mice Lacking the Gene Encoding for Dystrophin Circ. Res., December 13, 2002; 91(12): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rathaus and J. Bernheim Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension Nephrol. Dial. Transplant., February 1, 2002; 17(2): 216 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Henrion, N. Kubis, and B. I. Levy Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation Hypertension, November 1, 2001; 38(5): 1150 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suzuki, H. Ikezaki, D. Hong, and I. Rubinstein PGH2-TxA2-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension J Appl Physiol, June 1, 2000; 88(6): 1983 - 1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huang, D. Sun, and A. Koller Shear Stress-Induced Release of Prostaglandin H2 in Arterioles of Hypertensive Rats Hypertension, April 1, 2000; 35(4): 925 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Loufrani, D. Henrion, D. Chansel, R. Ardaillou, and B. I. Levy Functional Evidence for an Angiotensin IV Receptor in Rat Resistance Arteries J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 583 - 588. [Abstract] [Full Text] |
||||
![]() |
A. Koller and A. Huang Development of Nitric Oxide and Prostaglandin Mediation of Shear Stress-Induced Arteriolar Dilation With Aging and Hypertension Hypertension, November 1, 1999; 34(5): 1073 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Horstman, D. A. McCall, D. U. Frank, and G. F. Rich Inhaled Nitric Oxide and Nifedipine Have Similar Effects on Lung cGMP Levels in Rats Anesth. Analg., October 1, 1999; 89(4): 932 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matrougui, L. Loufrani, C. Heymes, B. I. Levy, and D. Henrion Activation of AT2 Receptors by Endogenous Angiotensin II Is Involved in Flow-Induced Dilation in Rat Resistance Arteries Hypertension, October 1, 1999; 34(4): 659 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Henrion, M. Iglarz, and B. I. Levy Chronic Endothelin-1 Improves Nitric Oxide–Dependent Flow-Induced Dilation in Resistance Arteries From Normotensive and Hypertensive Rats Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2148 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Qiu, D. Henrion, J. Benessiano, C. Heymes, B. Tournier, and B. I. Levy Decreased Flow-Induced Dilation and Increased Production of cGMP in Spontaneously Hypertensive Rats Hypertension, December 1, 1998; 32(6): 1098 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huang, D. Sun, G. Kaley, and A. Koller Superoxide Released to High Intra-arteriolar Pressure Reduces Nitric Oxide–Mediated Shear Stress– and Agonist-Induced Dilations Circ. Res., November 2, 1998; 83(9): 960 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iglarz, K. Matrougui, B. I. Levy, and D. Henrion Chronic blockade of endothelin ETA receptors improves flow dependent dilation in resistance arteries of hypertensive rats Cardiovasc Res, September 1, 1998; 39(3): 657 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matrougui, P. Schiavi, D. Guez, and D. Henrion High Sodium Intake Decreases Pressure-Induced (Myogenic) Tone and Flow-Induced Dilation in Resistance Arteries From Hypertensive Rats Hypertension, July 1, 1998; 32(1): 176 - 179. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |